Conmed Corp（CNMD）のニュースとイベントCNMDConmed Corp

CONMED Reports Q3 Revenue of $335.6M, Below Consensus

Reports Q3 revenue $335.6M, consensus $336.3M. "Our third quarter organic, constant currency net sales growth was consistent with our expectations and our adjusted diluted EPS exceeded them, reflecting our team's strong execution," said Patrick J. Beyer, CEO. "Importantly, our net sales growth on an organic, constant currency basis included balanced contributions from both our Orthopedic and General Surgery product lines, which were in turn powered by commercial traction across our key product growth platforms: AirSeal, Buffalo Filter, and BioBrace. Our updated full year guidance reflects this strong performance in the third quarter and our latest outlook as we close out the year. Looking ahead, our global team remains focused on executing our growth strategy to expand awareness and adoption of our key product platforms across the minimally invasive surgery, smoke evacuation, and orthopedic soft tissue repair markets. With a sharpened strategic focus on these key markets following our recent portfolio optimization activities, CONMED is better positioned to support our customers, expand our market share, and drive both long-term growth and value creation going forward."

Narrowed FY26 Revenue Outlook to $1.36B-$1.366B

Narrows FY26 revenue view to $1.36B-$1.366B from $1.358B-$1.373B

Avantor Appoints Todd Garner as EVP and CFO

Avantor (AVTR) appoints Todd Garner as EVP and CFO. Garner will oversee the company's global finance organization, including financial planning and analysis, accounting, treasury, tax, investor relations and internal audit. Garner recently comes from CONMED (CNMD), where he served as EVP and CFO from 2018-2026. Steve Eck, SVP and CAO, has been serving as Interim CFO since June 24, and will continue in his CAO role.